China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
RICHMOND, Calif., April 25, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the first quarter 2017 after the close of trading on Tuesday, May 9, 2017. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
Investors interested in listening to the conference call may do so by dialing (877) 407-3036 for domestic callers or (201) 378-4919 for international callers, using Conference ID: 13581989. A live webcast of the event will be available on the “Investors” section of the company’s website at: www.eksobionics.com.
A replay of the call will be available for two weeks by dialing (877) 660-6853 for domestic callers or (201) 612-7415 for international callers and using Conference ID: 13581989. The webcast will also be available on the company’s website for one month following the completion of the call.
About Ekso Bionics®
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities. The company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO. For more information, visit: www.eksobionics.com.
Media Contact: Carrie Yamond / Rajni Dhanjani 212-867-1788 [email protected] Investor Contact: Debbie Kaster 415-937-5403 [email protected]
